Champions Oncology, Inc. Common Stock (NASDAQ: CSBR) last traded at $4.96, down 4.25% on the session. The quote above updates while this page is open; the figures below are drawn from Champions Oncology, Inc. Common Stock’s own filings and are restated only when a new one is published.
Champions Oncology, Inc. Common Stock trades on NASDAQ under the ticker CSBR. Its market capitalisation is $68.91 million.
Valuation measures for Champions Oncology, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $68.91M |
|---|---|
| Enterprise value | $84.71M |
| Price / sales | 1.16 |
| Price / book | 17.49 |
| Beta | 0.34 |
Trailing-twelve-month figures tagged in Champions Oncology, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $59.42M |
|---|---|
| Net income (TTM) | -$1.18M |
| EPS (TTM) | -$0.0800 |
| Operating margin | -1.92% |
| Return on equity | -29.83% |
| Cash | $7.13M |
Range and volume for CSBR over the past 52 weeks.
| 52-week high | $8.74 |
|---|---|
| 52-week low | $4.83 |
| Volume | 8.1K |
| Average volume | 9.0K |
| Previous close | $5.18 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.